Solvotrin Therapeutics is an Irish healthcare development company focused on optimizing established therapies through innovative science with patent protection. Headquartered in Co. Cork, Ireland, Solvotrin has a team of 20 people with the R&D team members located at Trinity College Dublin. Driven by innovative science, Solvotrin redesigns essential medicinal and healthcare products, making them safer and more effective. Solvotrin’s approach has produced two distinct patent-protected platforms with applications in a wide array of medical settings. The first product range developed and successfully commercialised is the Active platform technology, led by a range of innovative oral iron products branded as Active Iron. Active Iron is clinically proven to be significantly better absorbed than the gold standard ferrous sulfate but uniquely avoids the negative gastrointestinal side effects commonly associated with oral iron. Active Iron is available in 12 markets worldwide. Learn more about Active Iron at activeiron.com
